Showing all 6 results
Darifenacin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrophilic Matrix Prolonged-Release Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute physical stability of the controlled-release polymer.
Active Ingredient Strength Primary Clinical Function Darifenacin Hydrobromide USP/Ph.Eur.
(Equivalent to Darifenacin base)7.5 mg (PR) The Standard Titration & Geriatric Anchor: The definitive, highly efficacious starting and maintenance dose utilized for the vast majority of patients to control OAB symptoms with minimal side effects. Darifenacin Hydrobromide USP/Ph.Eur. 15 mg (PR) The Severe Refractory Macrodose: High-efficacy therapeutic payload utilized strictly for patients who require greater symptom relief and have demonstrated high tolerability to the 7.5 mg dose. Excipients Hypromellose (HPMC) / Dibasic Calcium Phosphate / Magnesium Stearate / Polyethylene Glycol / Titanium Dioxide / Premium Polymeric Film Hydrophilic PR Matrix / Diluent / Lubricant / Plasticizer / Opaque Film (Engineered specifically utilizing high-viscosity Hypromellose. Upon contact with gastrointestinal fluids, the tablet hydrates to form a thick, gelatinous outer layer that strictly controls the diffusion of the highly soluble hydrobromide salt over a 24-hour period) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic urological dispensing regimens).
Silodosin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the active pharmaceutical ingredient.
Active Ingredient Strength Primary Clinical Function Silodosin INN/Ph.Eur. 8 mg Global Clinical Standard: Maximum adult daily dose for the rapid relief of lower urinary tract symptoms (LUTS) associated with BPH. Excipients Mannitol / Pregelatinized Starch / Sodium Stearyl Fumarate / Hypromellose / Titanium Dioxide Diluent / Binder / Lubricant / Film-Coating (Engineered for highly synchronized gastric dissolution and optimal bioavailability) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for high-compliance 30-day urology dispensing regimens).
Solifenacin Succinate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or High-Density Alu-PVC blister strips to ensure the absolute stability of the low-dose API.
Active Ingredient Strength Primary Clinical Function Solifenacin Succinate USP/Ph.Eur. 5 mg Global Standard: Starting and standard maintenance dose for Overactive Bladder; required maximum dose for patients with hepatic/renal impairment. Solifenacin Succinate USP/Ph.Eur. 10 mg High-Dose Therapy: Maximum adult dose for severe, refractory urinary urgency and frequency. Excipients Lactose Monohydrate / Maize Starch / Hypromellose / Magnesium Stearate / Macrogol Diluent / Binder / Premium Film-Coating (Engineered for immediate gastric dissolution and light protection) Tamsulosin & Dutasteride Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Bilayer Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant and child-resistant Alu-Alu blister strips to ensure the absolute stability of both the kinetic polymer matrix and the sensitive hormonal API.
Active Ingredient Strength Primary Clinical Function Tamsulosin Hydrochloride USP/Ph.Eur. 0.4 mg (Modified-Release) Continuous 24-hour uro-selective alpha-1A blockade for immediate symptom relief. Dutasteride USP/Ph.Eur. 0.5 mg Dual 5-alpha-reductase inhibition for profound DHT suppression and prostate volume reduction. Excipients Hypromellose (HPMC) / Butylated Hydroxytoluene (BHT) / Microcrystalline Cellulose / Magnesium Stearate SR Polymer matrix for Tamsulosin / Antioxidant stabilizer for solid-state Dutasteride (Engineered for strict segregation) Tamsulosin & Finasteride Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Bilayer Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant and child-resistant Alu-Alu blister strips to ensure the absolute stability of both the kinetic polymer matrix and the sensitive hormonal API.
Active Ingredient Strength Primary Clinical Function Tamsulosin Hydrochloride USP/Ph.Eur. 0.4 mg (Modified-Release) Continuous 24-hour uro-selective alpha-1A blockade for immediate symptom relief. Finasteride USP/Ph.Eur. 5 mg Targeted Type II 5-alpha-reductase inhibition for profound DHT suppression and prostate shrinkage. Excipients Hypromellose (HPMC) / Microcrystalline Cellulose / Sodium Starch Glycolate / Magnesium Stearate SR Polymer matrix for Tamsulosin / Diluent for Finasteride (Engineered for strict kinetic segregation) Tamsulosin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Gel-Matrix Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute stability of the hygroscopic polymers.
Active Ingredient Strength Primary Clinical Use Tamsulosin Hydrochloride USP/Ph.Eur. 0.4 mg (Modified-Release Tablet) Premium Global Standard: Target once-daily, food-independent adult dose for BPH. Excipients Macrogol (Polyethylene Glycol) / Magnesium Stearate / Hypromellose / Iron Oxide Advanced Non-Ionic Gel Matrix / Lubricant / Film Coat (Engineered for strict 24-hour continuous diffusion)
